Abbott SCSPENDING
Nevro SCSPENDING
Apple AirTagPENDING
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
ACTIVE
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
ACTIVE
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
QUIET
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
MONITOR
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
MONITOR
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
MONITOR
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
QUIET
Dupixent CTCL
MONITOR
Boston Sci. SCS
MONITOR
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
25Active
3Pending
Navigation
Abbott SCSPENDING
Nevro SCSPENDING
Apple AirTagPENDING
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
ACTIVE
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
ACTIVE
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
QUIET
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
MONITOR
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
MONITOR
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
MONITOR
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
QUIET
Dupixent CTCL
MONITOR
Boston Sci. SCS
MONITOR
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
25Active
3Pending
LexGenius Logo
LexGeniusYour Edge in Mass Litigation
PricingDaily DocketTrack litigations freeSign in
LexGenius

LexGenius

Your Edge in Mass Litigation

DisclaimerAcceptable UseTermsPrivacyCookie PolicySupport

© 2026 LexGenius. All rights reserved.

← All Briefs

Daily Intelligence Brief

Tuesday, August 25, 2026

Docket Roundup: Five MDLs Concentrate the Day’s Intake

Filing volume tightened around five repeat-player dockets, with concentrated firm channels rather than diffuse intake driving the day’s movement. Zantac Products Liability Litigation (2924) led with 19 filings, all from Keller Postman LLC, while Uber Technologies, Inc., Passenger Sexual Assault Litigation (3084) followed with 17 cases through Chaffin Luhana LLP. Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (3060) logged 10 filings, with Peiffer Wolf filing six and Douglas & London three, while Aqueous Film-Forming Foams Personal Injury Products Liability Litigation (2873) added six as Krentsel & Guzman LLP filed three and Environmental Litigation Group PC filed one. Glucagon-like Peptide-1 Receptor Agonists Products Liability (Gastroparesis) Litigation (3094) rounded out the group with five matters led by Levin Papantonio’s three and Morgan & Morgan PA’s one, reinforcing how a limited roster of firms is setting the docket’s immediate pace. See the full filing feed and firm-level breakdowns here.

California’s Youth-Feed Law Stays in Force During Appeal

A federal judge on Aug. 25 left California’s Protecting Our Kids from Social Media Addiction Act enforceable while platform defendants pursue their appeal, preserving parental-consent requirements for personalized feeds. The court concluded that the companies had not shown their predictive recommendation systems communicate an expressive message and declined to treat projected compliance costs as irreparable harm. The refusal to pause enforcement does not resolve the constitutional appeal, but it puts live product-control obligations alongside the evidence disputes confronting the industry. In Social Media Adolescent Addiction/Personal Injury Products Liability Litigation (3047), the ruling can focus discovery on how defendants identify minor users, obtain consent, configure recommendations and limit notifications.

Pennsylvania Sets Sept. 2 PFAS Biosolids Comment Deadline

Pennsylvania’s proposed biosolids permits face a Sept. 2 public-comment deadline, forcing wastewater facilities and affected stakeholders to address conditions aimed at reducing PFOA and PFOS releases onto farm fields. The draft PAG-07, PAG-08 and PAG-09 permit terms would require quarterly PFAS testing and require facilities exceeding proposed thresholds to develop plans for reducing PFAS entering their treatment systems. The proposal is not a statewide ban and the permit terms are not final, but the proceeding will establish a defined record on source control and PFAS migration through wastewater residuals. That regulatory record can sharpen environmental-pathway and cleanup-allocation disputes in Aqueous Film-Forming Foams Personal Injury Products Liability Litigation (2873).

Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.